Cervical spondylotic radiculopathy
Conditions
Interventions
TCM treatment group for Qi stagnation and blood stasis syndrome:1. Acupuncture Therapy
Acupoint selection followed the principles of unblocking meridians, promoting qi movement and blood circulation,
TCM treatment group for liver and kidney deficiency syndrome:1. Acupuncture Therapy
Acupoint selection followed the principles of dredging meridians, tonifying the liver and kidney, alleviating pain i
Sponsors
School of Public Health, Cheeloo College of Medicine, Shandong University
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18 to 75 years, regardless of gender. 2. Meets the Western medical diagnostic criteria for cervical radiculopathy, with at least one valid cervical MRI imaging report within the past 3 months supporting the diagnosis. 3. Independently diagnosed by two senior traditional Chinese medicine practitioners as having one of the following four TCM syndrome types: Qi stagnation and blood stasis syndrome, Liver and Kidney deficiency syndrome, Wind-cold-dampness bi syndrome, or Qi and blood deficiency syndrome. If concurrent syndromes exist, the dominant syndrome type will be used for assignment to the corresponding study arm. 4. Baseline Visual Analogue Scale (VAS) score for neck, shoulder, and upper limb pain >= 4. 5. This episode is either the first onset or a recurrence, and the patient has not received epidural nerve block injection, radiofrequency ablation, or open surgical treatment within 1 week prior to enrollment. 6. The subject has been fully informed and voluntarily signs the written informed consent form, agrees not to receive other traditional Chinese or Western physical therapies or potent analgesic medications outside the study protocol during the trial period, and is able to comply with the treatment and follow-up schedule.
Exclusion criteria
Exclusion criteria: 1. Patients with cervical spondylotic myelopathy or vertebral artery type cervical spondylosis causing severe vertigo and syncope, or those with clear indications for emergency decompressive surgery. 2. Congenital malformations, acute fractures, dislocations, tuberculosis, purulent infections, primary or metastatic malignant bone tumors at the cervical spine. 3. Severe skin lesions, active ulcers, purulent infections, or severe dermatitis at the intended treatment site that would prevent safe performance of acupuncture, tuina, moxibustion, cupping, TENS, or other procedures. 4. Severe coagulation disorders or long-term use of potent anticoagulants, resulting in high bleeding risk during bloodletting and cupping. 5. Unstable severe cardiovascular or cerebrovascular diseases, severe hepatic or renal insufficiency, malignant hematopoietic diseases, or severe psychiatric disorders that impede normal communication and expression. 6. Female participants who are pregnant, breastfeeding, or planning to become pregnant within the next six months. 7. Participation in other investigational drug or medical device clinical trials within the past 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Neurological Examination;Neck Disability Index (NDI);Traditional Chinese Medicine Syndrome Score;Visual Analogue Scale, VAS; | — |
Secondary
| Measure | Time frame |
|---|---|
| Metabolic Biomarkers / Metabolomic Outcomes;Medical Infrared Thermography Outcomes / TMT-based Thermal Imaging Outcomes;Inflammatory Biomarkers;Treatment-related Local Adverse Reactions; | — |
Countries
China
Contacts
Public ContactXue Fuzhong
School of Public Health, Cheeloo College of Medicine, Shandong University
Outcome results
None listed